Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
Novo Nordisk A\/S (NVO) stocks are traded on NYSE.
The stock ticker of Novo Nordisk A\/S’s stocks or in other words, the code is NVO. The stocks are currently listed on the NYSE exchange.
Novo Nordisk A\/S (NVO) stocks are traded on the NYSE exchange in dollars.
The current price of Novo Nordisk A\/S stocks on 06.07.2022 is 111.24 dollars. per share.
Novo Nordisk A\/S (NVO) quotes have increased by 0% from the beginning of the year up to 111.24 dollars. per 1 stocks.
This month Novo Nordisk A\/S (NVO) quotes have increased by -0.36% to 111.24 dollars. per share.
Today, on October, 06.07.2022 Novo Nordisk A\/S’s (NVO) stocks cost 111.24 dollars..
Capitalization is the market value of Novo Nordisk A\/S (NVO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 06.07.2022, the market capitalization of Novo Nordisk A\/S (NVO) is estimated at about 253994292000 dollars.